Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure Podcast Por  arte de portada

Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure

Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure

Escúchala gratis

Ver detalles del espectáculo
In today’s Pharmaceutical Executive Daily learn how Novo Nordisk is restructuring leadership to enhance scientific and commercial alignment, ABL Bio secures a major multi-program partnership with Eli Lilly, and the FDA launches its new Plausible Mechanism Pathway to accelerate drug development.
Todavía no hay opiniones